The head of the U.S. agency that enforces laws banning workplace discrimination on Monday warned 20 major law firms that ...

The transformation to digital data has increased the importance of including technical details surrounding digital data in ...

Incyte Corporation (NASDAQ:INCY) revealed results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and ...

Several counties in the Houston area are seeing some of the fastest population growth in the country.

Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from ...

Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

Introduction: Data science is transforming various industries, including healthcare and finance, and it's projected that ...

Houston saw a massive influx of residents from July 2023 to 2024, according to newly released data from the U.S. Census ...

Compact wireless numeric keypad featuring full-size keys and ergonomic tilt, perfect for accurate data entry in spreadsheets ...

Incyte's Phase 3 TRuE-PN trials show ruxolitinib cream improves itch relief in prurigo nodularis, though TRuE-PN2's primary ...

Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...